Treatment of Osteoporosis in an 85-Year-Old Female with Humerus Fracture
The optimal treatment approach for this 85-year-old female with a right humerus fracture and osteoporosis should include immediate fracture management followed by oral bisphosphonate therapy, along with calcium and vitamin D supplementation.
Acute Fracture Management
Initial Management
- Appropriate immobilization of the right humerus fracture
- Pain management with multimodal analgesia
- Early mobilization as tolerated to prevent complications of immobility 1
- Consider orthopedic consultation for fracture stabilization if indicated
Osteoporosis Treatment
First-Line Pharmacologic Therapy
- Oral bisphosphonate therapy is the recommended first-line treatment for this patient with osteoporosis and a recent fragility fracture 1
- Options include:
- Alendronate 70 mg weekly
- Risedronate 35 mg weekly
- Ibandronate 150 mg monthly
- Options include:
Calcium and Vitamin D Supplementation
Alternative Therapies (if oral bisphosphonates are contraindicated)
In order of preference:
- Intravenous bisphosphonates (zoledronic acid 5 mg annually) 1
- Denosumab 60 mg subcutaneously every 6 months 1, 3
- Particularly beneficial for patients with renal insufficiency
- Teriparatide 20 mcg subcutaneously daily 4
- Consider for very high-risk patients with severe osteoporosis
Comprehensive Care Approach
Fall Prevention
- Home safety assessment and modification
- Balance and strength training exercises
- Review of medications that may increase fall risk
- Vision assessment
- Appropriate footwear
Lifestyle Modifications
- Weight-bearing and resistance exercises as tolerated
- Smoking cessation if applicable
- Limiting alcohol consumption to 1-2 drinks per day
- Balanced diet rich in calcium 5
Follow-up Care
- Bone mineral density (BMD) testing to monitor treatment response
- First follow-up DXA scan 1-2 years after initiating therapy 1
- Regular assessment of medication adherence and side effects
- Periodic reassessment of fracture risk
Important Considerations
Age-Specific Factors
- At 85 years of age, this patient is at very high risk for subsequent fractures
- The presence of a fragility fracture alone is sufficient to diagnose osteoporosis and initiate treatment, even without DXA confirmation 1
Treatment Duration
- Initial treatment duration of 3-5 years
- Reassess fracture risk after this period to determine need for continued therapy
Monitoring for Adverse Effects
- Monitor for potential side effects of bisphosphonates:
- Gastrointestinal issues with oral formulations
- Atypical femoral fractures (rare but serious)
- Osteonecrosis of the jaw (rare, primarily with IV formulations)
Pitfalls to Avoid
- Do not delay osteoporosis treatment while waiting for fracture healing
- Do not rely solely on calcium and vitamin D without pharmacologic therapy in a patient with established osteoporosis and fracture 5
- Do not overlook the need for a comprehensive approach including fall prevention
- Avoid assuming that age alone is a contraindication to pharmacologic therapy 6
By implementing this treatment approach, the patient's risk of subsequent fractures can be significantly reduced, improving her morbidity, mortality, and quality of life outcomes.